TY - JOUR
T1 - A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis
AU - Barnes, Hayley
AU - Morisset, Julie
AU - Molyneaux, Philip
AU - Westall, Glen
AU - Glaspole, Ian
AU - Collard, Harold R.
AU - CHP Exposure Assessment Collaborators
AU - Antoniou, Katerina M.
AU - Barber, Christopher M.
AU - Behr, Jürgen
AU - Bonella, Francesco
AU - Corte, Tamera
AU - Costabel, Ulrich
AU - Cottin, Vincent
AU - Crestani, Bruno
AU - Dalphin, Jean Charles
AU - Flaherty, Kevin R.
AU - Goh, Nicole
AU - Johannson, Kerri A.
AU - Kondoh, Yasuhiro
AU - Lederer, David
AU - Lee, Joyce
AU - Maher, Toby M.
AU - Martinez, Fernando J.
AU - Morell, Ferran
AU - Noth, Imre
AU - Raghu, Ganesh
AU - Renzoni, Elisabetta
AU - Richeldi, Luca
AU - Ryerson, Christopher J.
AU - Ryu, Jay H.
AU - Salisbury, Margaret L.
AU - Singh, Sheetu
AU - Selman, Moises
AU - Strek, Mary E.
AU - Tarlo, Susan M.
AU - Tomassetti, Sara
AU - Vancheri, Carlo
AU - Vasakova, Martina
AU - Wolters, Paul
AU - Wells, Athol
PY - 2020/6
Y1 - 2020/6
N2 - Background: Chronic hypersensitivity pneumonitis (CHP) is an immune-mediated interstitial lung disease (ILD) caused by inhalational exposure to environmental antigens, resulting in parenchymal fibrosis. By definition, a diagnosis of CHP assumes a history of antigen exposure, but only half of all patients eventually diagnosed with CHP will have a causative antigen identified. Individual clinician variation in eliciting a history of antigen exposure may affect the frequency and confidence of CHP diagnosis. Methods: A list of potential causative exposures were derived from a systematic review of the literature. A Delphi method was applied to an international panel of ILD experts to obtain consensus regarding technique for the elicitation of exposure to antigens relevant to a diagnosis of CHP. The consensus threshold was set at 80% agreement, and median ≤ 2, interquartile range = 0 on a 5-point Likert scale (1, strongly agree; 2, tend to agree; 3, neither agree nor disagree; 4, disagree; 5, strongly disagree). Results: In two rounds, 36/40 experts participated. Experts agreed on 18 exposure items to ask every patient with suspected CHP. Themes included CHP inducing exposures, features that contribute to an exposure's relevance, and quantification of a relevant exposure. Based on the results from the literature review and Delphi process, a CHP exposure assessment instrument was derived. Using cognitive interviews, the instrument was revised by patients with ILD for readability and usability. Conclusions: This Delphi survey provides items that ILD experts agree are important to ask in all patients presenting with suspected CHP and provides basis for a systematically derived CHP exposure assessment instrument. Clinical utility of this exposure assessment instrument may be affected by different local prevalence patterns of exposures. Ongoing research is required to clinically validate these items and consider their impact in more geographically diverse settings.
AB - Background: Chronic hypersensitivity pneumonitis (CHP) is an immune-mediated interstitial lung disease (ILD) caused by inhalational exposure to environmental antigens, resulting in parenchymal fibrosis. By definition, a diagnosis of CHP assumes a history of antigen exposure, but only half of all patients eventually diagnosed with CHP will have a causative antigen identified. Individual clinician variation in eliciting a history of antigen exposure may affect the frequency and confidence of CHP diagnosis. Methods: A list of potential causative exposures were derived from a systematic review of the literature. A Delphi method was applied to an international panel of ILD experts to obtain consensus regarding technique for the elicitation of exposure to antigens relevant to a diagnosis of CHP. The consensus threshold was set at 80% agreement, and median ≤ 2, interquartile range = 0 on a 5-point Likert scale (1, strongly agree; 2, tend to agree; 3, neither agree nor disagree; 4, disagree; 5, strongly disagree). Results: In two rounds, 36/40 experts participated. Experts agreed on 18 exposure items to ask every patient with suspected CHP. Themes included CHP inducing exposures, features that contribute to an exposure's relevance, and quantification of a relevant exposure. Based on the results from the literature review and Delphi process, a CHP exposure assessment instrument was derived. Using cognitive interviews, the instrument was revised by patients with ILD for readability and usability. Conclusions: This Delphi survey provides items that ILD experts agree are important to ask in all patients presenting with suspected CHP and provides basis for a systematically derived CHP exposure assessment instrument. Clinical utility of this exposure assessment instrument may be affected by different local prevalence patterns of exposures. Ongoing research is required to clinically validate these items and consider their impact in more geographically diverse settings.
KW - extrinsic allergic alveolitis
KW - hypersensitivity pneumonitis
KW - interstitial lung diseases
UR - http://www.scopus.com/inward/record.url?scp=85084230313&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2019.12.018
DO - 10.1016/j.chest.2019.12.018
M3 - Article
C2 - 31958445
AN - SCOPUS:85084230313
VL - 157
SP - 1506
EP - 1512
JO - Chest
JF - Chest
SN - 0012-3692
IS - 6
ER -